Recently, various non-peptide corticotropin-releasing factor1 (CRF1) receptor antagonists have been reported. Structure–affinity relationships (SARs) of non-peptide CRF1 antagonists suggest that such antagonists can be constructed of three units: a hydrophobic unit (Up-Area), a proton accepting unit (Central-Area), and an aromatic unit (Down-Area). We previously presented 4-aryl-1, 2, 3, 6-tetrahydropyridinopyrimidine derivatives ...